Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen announces data from romosozumab, Prolia studies
Amgen announces data from romosozumab, Prolia studies
Amgen announces data from romosozumab, Prolia studies
Submitted by
admin
on October 4, 2013 - 11:17am
Source:
The Fly on the Wall
News Tags:
Amgen
romosozumab
Prolia
UCB
bone mineral density
Headline:
Amgen announces data from romosozumab, Prolia studies
Do Not Allow Advertisers to Use My Personal information
